Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease
NCT03962881Phase 4Unknown
- Sponsor
- Shanxi Medical University
- Start
- May 2019
- Primary completion
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV), sponsored by Shanxi Medical University. Status: unknown.
02
Drugs
recombinant hepatitis B vaccine Bio Farma
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03962881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962881.